Global Research Initiative for Patients screening on Metabolic dysfunction-Associated Steato – Hepatitis is an ambitious study of a disease affecting an estimated 30% of the World’s population: the steatotic (or fatty) liver. This research is sponsored by the Innovative Health Initiative Joint Undertaking, where the EU’s Horizon Europe programme has partenered with several distinguished research, pharmaceutical, IT and financial institutions in Europe.
Around ten thousand subjects will be recruited, in at least 10 EU centers. MERIC is the Romanian partner and will recruit 1000 Romanian patients in Sacele.
People enrolled in the study will receive advice on adequate lifestyle and nutrition, meant to cure the fatty liver or reduce the risk of progression to the more severe stages.
see more on GRIPonMASH









